Green Cross becomes the fourth company succeeding in acquisition of tetravalent vaccine approval

On the 26^th, Green Cross(CEO Eun-cheol Huh) announced acquisition of product approval of G C Flu Pre-filled Syringe Inj, a tetravalent influenza(flu) vaccine, from the Ministry of Food and Drug Safety.

Among other Asian pharmaceutical companies, Green Cross is the only company which acquired approval of a tetravalent flu vaccine. In the global market, the company became the fourth one after Gl...